POM
POMDOCTOR LIMITED American Depositary Shares
NASDAQ: POM · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.38
+2.21% today
Updated 2026-04-30
Market cap
$50.01M
P/E ratio
—
P/S ratio
0.14x
EPS (TTM)
$-0.05
Dividend yield
—
52W range
$0 – $6
Volume
1.3M
POMDOCTOR LIMITED American Depositary Shares (POM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.06B | $8.36B | $9.37B | $10.70B | $9.26B | $7.04B | $5.92B | $5.08B | $4.67B | $4.88B | $5.02B | $31.36B | $33.53B | $35.98B | $34.44B | $141.21M | $215.38M | $245.22M | $304.85M | $342.56M |
| Revenue growth (YoY) | — | +3.7% | +12.0% | +14.2% | -13.5% | -24.0% | -15.9% | -14.2% | -8.2% | +4.5% | +3.0% | +524.3% | +6.9% | +7.3% | -4.3% | -99.6% | +52.5% | +13.9% | +24.3% | +12.4% |
| Cost of revenue | $712.00M | $649.00M | $606.00M | $718.00M | $403.00M | $127.00M | $172.00M | $170.00M | $146.00M | $207.00M | $175.00M | $12.64B | $14.04B | $16.67B | $15.50B | $87.48M | $162.88M | $190.36M | $266.13M | $294.86M |
| Gross profit | $7.35B | $7.71B | $8.76B | $9.98B | $8.86B | $6.91B | $5.75B | $4.91B | $4.52B | $4.67B | $4.85B | $18.72B | $19.50B | $19.32B | $18.94B | $53.72M | $52.51M | $54.86M | $38.72M | $47.69M |
| Gross margin | 91.2% | 92.2% | 93.5% | 93.3% | 95.6% | 98.2% | 97.1% | 96.7% | 96.9% | 95.8% | 96.5% | 59.7% | 58.1% | 53.7% | 55.0% | 38.0% | 24.4% | 22.4% | 12.7% | 13.9% |
| R&D | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $1.99M | $4.28M | $3.59M | $3.37M | $3.00M |
| SG&A | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $11.55M | $18.85M | $7.41M | $12.31M | $11.88M |
| Operating income | $905.00M | $693.00M | $806.00M | $768.00M | $695.00M | $160.00M | $637.00M | $670.00M | $668.00M | $604.00M | $673.00M | $3.11B | $4.26B | $3.90B | $4.37B | $-240.42M | $-79.67M | $-3.59M | $-22.25M | $-25.79M |
| Operating margin | 11.2% | 8.3% | 8.6% | 7.2% | 7.5% | 2.3% | 10.8% | 13.2% | 14.3% | 12.4% | 13.4% | 9.9% | 12.7% | 10.8% | 12.7% | -170.3% | -37.0% | -1.5% | -7.3% | -7.5% |
| EBITDA | $969.00M | $750.00M | $862.00M | $798.00M | $715.00M | $291.00M | $966.00M | $1.22B | $854.00M | $1.20B | $1.39B | $8.97B | $9.52B | $8.02B | $5.12B | $-221.54M | $-58.58M | $-3.81M | $-22.99M | $-24.27M |
| EBITDA margin | 12.0% | 9.0% | 9.2% | 7.5% | 7.7% | 4.1% | 16.3% | 24.0% | 18.3% | 24.6% | 27.7% | 28.6% | 28.4% | 22.3% | 14.9% | -156.9% | -27.2% | -1.6% | -7.5% | -7.1% |
| EBIT | $963.00M | $748.00M | $860.00M | $768.00M | $695.00M | $161.00M | $539.00M | $706.00M | $380.00M | $648.00M | $736.00M | $3.39B | $4.09B | $2.05B | $4.62B | $-242.49M | $-79.89M | $-3.59M | $-23.10M | $-24.40M |
| Interest expense | $337.00M | $339.00M | $339.00M | $330.00M | $370.00M | $65.00M | $254.00M | $265.00M | $273.00M | $268.00M | $280.00M | $1.50B | $1.52B | $1.53B | $1.59B | $14.00M | $16.29M | $16.02M | $13.85M | $12.96M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $371.00M | $248.00M | $334.00M | $300.00M | $235.00M | $53.00M | $257.00M | $285.00M | $-212.00M | $242.00M | $327.00M | $1.13B | $2.69B | $398.00M | $3.03B | $-256.44M | $-188.40M | $-125.51M | $-145.39M | $-143.36M |
| Net income growth (YoY) | — | -33.2% | +34.7% | -10.2% | -21.7% | -77.4% | +384.9% | +10.9% | -174.4% | +214.2% | +35.1% | +246.8% | +137.6% | -85.2% | +660.8% | -108.5% | +26.5% | +33.4% | -15.8% | +1.4% |
| Profit margin | 4.6% | 3.0% | 3.6% | 2.8% | 2.5% | 0.8% | 4.3% | 5.6% | -4.5% | 5.0% | 6.5% | 3.6% | 8.0% | 1.1% | 8.8% | -181.6% | -87.5% | -51.2% | -47.7% | -41.9% |